ClinicalTrials.gov record
Completed Phase 2 Interventional

Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia

ClinicalTrials.gov ID: NCT00029380

Public ClinicalTrials.gov record NCT00029380. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 3:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Sibling Donor Cord Blood Banking and Transplantation

Study identification

NCT ID
NCT00029380
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Enrollment
30 participants

Conditions and interventions

Interventions

  • Busulfan Drug
  • Cord Blood Transplantation Procedure
  • Cyclophosphamide Drug
  • Cyclosporine Drug
  • Mycophenolate Mofetil Drug
  • Sangstat Drug

Drug · Procedure

Eligibility (public fields only)

Age range
3 Years to 14 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 1998
Primary completion
Jul 31, 2006
Completion
Jul 31, 2006
Last update posted
Jul 28, 2016

1999 – 2006

United States locations

U.S. sites
14
U.S. states
11
U.S. cities
13
Facility City State ZIP Site status
Children's Hospital Oakland Oakland California 94609
Children's Hospital, Oakland Oakland California 94609
Children's National Medical Center Washington D.C. District of Columbia
Nemours Children's Clinic Jacksonville Florida 32207
University of Miami Batchelor Children's Research Center Miami Florida 33136
Children's Memorial Hospital Chicago Illinois 60614
Louisiana State University Children's Medical Center New Orleans Louisiana
University of Michigan Ann Arbor Michigan 48109
Hackensack University Medical Center Hackensack New Jersey 07601
Duke University Medical Center Children's Hospital Durham North Carolina
Children's Hospital Philadelphia Philadelphia Pennsylvania 19104
Medical University of South Carolina Charleston South Carolina 29403
University of Texas Southwestern Medical Center - Dallas Dallas Texas 75235
Texas Transplant Institute San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00029380, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 28, 2016 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00029380 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →